Skip to content
    Compare notes on r/BodyHackGuideCompare notes with other researchers. Join r/BodyHackGuide
    NootropicsPhase 2

    Neboglamine (CR 2249) Dosage Guide: Protocols, Calculator & Safety

    Everything you need to know about Neboglamine (CR 2249) dosing: protocols, safety, and where to buy.

    Half-Life

    Not established. No human or animal pharmacokinetic study for neboglamine has been published, and no phase 1 data are available.

    Administration Routes

    Oral

    Dosage Calculator

    Calculate exact dosing for Neboglamine (CR 2249).

    Dosing data for Neboglamine (CR 2249) is being researched. Check the compound page for the latest information.

    Side Effects & Safety

    No human safety data have been published. Phase 2 work in schizophrenia and cocaine dependence is listed in commercial pipeline databases but no results have appeared in the peer-reviewed literature, and no trial records were found on ClinicalTrials.gov or the EU Clinical Trials Register. In rats, oral neboglamine inhibited phencyclidine-induced hyperlocomotion without affecting basal locomotor activity, and unlike haloperidol it did not produce the large activation of the dorsolateral striatum associated with movement side effects (PMID: 20045056). In earlier rodent studies no changes in general behavior or motor activity were observed at the doses tested (PMID: 9004193). None of that substitutes for a human safety dataset.

    Contraindications

    None established. No human safety, pharmacokinetic, drug interaction, pregnancy, lactation or organ impairment data have been published. Mechanism-based caution: neboglamine increases NMDA receptor function rather than blocking it, increasing [3H]MK-801 binding in a concentration-dependent manner in rat tissue (PMID: 9294970), which is a theoretical excitotoxicity concern for anyone with a seizure disorder, recent stroke or acute brain injury. The compound was investigated as an antipsychotic-like agent in a phencyclidine model (PMID: 20045056), so interaction with psychiatric medication is plausible but has never been studied.

    Check interactions with the Interaction Checker →

    Frequently Asked Questions

    What is the recommended Neboglamine (CR 2249) dosage?

    Dosage for Neboglamine (CR 2249) varies by protocol. Consult a qualified healthcare provider.

    How often should I take Neboglamine (CR 2249)?

    Administration frequency depends on the specific protocol. Consult current research literature.

    Does Neboglamine (CR 2249) need to be cycled?

    Cycling requirements depend on the protocol. Follow established research guidelines.

    What are Neboglamine (CR 2249) side effects?

    No human safety data have been published. Phase 2 work in schizophrenia and cocaine dependence is listed in commercial pipeline databases but no results have appeared in the peer-reviewed literature, and no trial records were found on ClinicalTrials.gov or the EU Clinical Trials Register. In rats, oral neboglamine inhibited phencyclidine-induced hyperlocomotion without affecting basal locomotor activity, and unlike haloperidol it did not produce the large activation of the dorsolateral striatum associated with movement side effects (PMID: 20045056). In earlier rodent studies no changes in general behavior or motor activity were observed at the doses tested (PMID: 9004193). None of that substitutes for a human safety dataset.

    Where can I buy Neboglamine (CR 2249)?

    Compare 1 listings from 1 vendor on our price comparison page, starting from $69.99.

    Free 2026 Peptide Cheat Sheet (PDF)

    38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers.

    Download Free